H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.3% of adults in Midland have diagnosed diabetes — 0.7 points below the U.S. 12% figure. Census population 138,933. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Midland clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Midland storefront.
Joint Preservation Therapy Solutions in Midland, TX for clinics & physicians. Joint preservation therapy h… Compliance support & pricing — contact Hawk Medical.
19.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 11.3% of adults in Midland have diagnosed diabetes — 0.7 points below the U.S. 12% figure. Population 138,933. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JH documentation are ready before the first application of joint preservation therapy.
National Joint Preservation Therapy Solutions notes (how the product actually works)Three grains, kept separate on purpose. City: Census 138,933 and CDC PLACES crude rates. State: Texas DSHS, Diabetes Belt counties present. Federal: 21 CFR 1271 and Novitas Solutions LCDs. CDC PLACES (2023, crude) estimates 11.3% of adults in Midland have diagnosed diabetes — 0.7 points below the U.S. 12% figure.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 11.3% of adults in Midland have diagnosed diabetes — 0.7 points below the U.S. 12% figure. Adult arthritis here is 20.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Midland.
CDC PLACES (2023, crude prevalence) estimates 11.3% of adults — 0.7 points below the U.S. 12% figure. Obesity is 36%; arthritis is 20.3%. That is place-level BRFSS modeling, not a clinic census and not a Midland trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JH reviewers and surveyors expect — not a brochure.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a Texas audit trail stays clean.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Texas.
Bring specialty, monthly joint / regenerative volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 11.3% diabetes and 20.3% arthritis for Midland — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Midland, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Midland is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Midland — 0.7 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Midland. Useful for joint-program math; still needs a diagnosis and privileging.
No Midland storefront. Joe Bradley is an active practice owner. joint preservation therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.